Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  fluorine F 18 sodium fluoride
Find trials that include:  Any drugs shown
Results 1-6 of 6 for your search:
Start Over
F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets
Status: Active
Phase: Phase III
Type: Diagnostic
Age: 18 and over
Trial IDs: AMI-2008-01, NCI-2014-02587, NCT00882609
Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients with Recurrent Prostate Cancer
Status: Active
Phase: Phase II
Type: Diagnostic
Age: 18 and over
Trial IDs: 13365, NCI-2013-01924, 114288, NCT01967862
A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: MDV3100-18, NCI-2015-01542, NCT02384382
Fluorine F 18 Sodium Fluoride and Fludeoxyglucose F 18 Combined Positron Emission Tomography/Computed Tomography Scan in Diagnosing Patients With Skeletal Neoplasms
Status: Active
Phase: No phase specified
Type: Diagnostic
Age: Over 18
Trial IDs: VAR0024, NCI-2011-00804, 9434, 98043, NCT00725387
Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients with Hormone Resistant Metastatic Prostate Cancer
Status: Not yet active
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: 8021, NCI-2014-01203, NCT02169063
NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients with Metastatic Hormone-Resistant Prostate Cancer
Status: Active
Phase: No phase specified
Type: Diagnostic
Age: 19 and over
Trial IDs: PROS0063, NCI-2015-00553, 96754, ep 32653, NCT02429804
Start Over